Literature DB >> 7896884

Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues.

K L Taneja1, M McCurrach, M Schalling, D Housman, R H Singer.   

Abstract

We have analyzed the intracellular localization of transcripts from the myotonin protein kinase (Mt-PK) gene in fibroblasts and muscle biopsies from myotonic dystrophy patients and normal controls. In affected individuals, a trinucleotide expansion in the gene results in the phenotype, the severity of which is proportional to the repeat length. A fluorochrome-conjugated probe (10 repeats of CAG) hybridized specifically to this expanded repeat. Mt-PK transcripts containing CTG repeat expansions were detected in the nucleus as bright foci in DM patient fibroblasts and muscle biopsies, but not from normal individuals. These foci represented transcripts from the Mt-PK gene since they simultaneously hybridized to fluorochrome-conjugated probes to the 5'-end of the Mt-PK mRNA. A single oligonucleotide probe to the repeat and the sense strand each conjugated to different fluorochromes revealed the gene and the transcripts simultaneously, and indicated that these focal concentrations (up to 13 per nucleus) represented predominately posttranscriptional RNA since only a single focus contained both the DNA and the RNA. This concentration of nuclear transcripts was diagnostic of the affected state, and may represent aberrant processing of the RNA.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7896884      PMCID: PMC2120416          DOI: 10.1083/jcb.128.6.995

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  28 in total

1.  Progression of the cell cycle through mitosis leads to abortion of nascent transcripts.

Authors:  A W Shermoen; P H O'Farrell
Journal:  Cell       Date:  1991-10-18       Impact factor: 41.582

2.  Factor required for mammalian spliceosome assembly is localized to discrete regions in the nucleus.

Authors:  X D Fu; T Maniatis
Journal:  Nature       Date:  1990-02-01       Impact factor: 49.962

3.  Highly localized tracks of specific transcripts within interphase nuclei visualized by in situ hybridization.

Authors:  J B Lawrence; R H Singer; L M Marselle
Journal:  Cell       Date:  1989-05-05       Impact factor: 41.582

4.  Three-dimensional molecular distribution in single cells analysed using the digital imaging microscope.

Authors:  F S Fay; W Carrington; K E Fogarty
Journal:  J Microsc       Date:  1989-02       Impact factor: 1.758

5.  Efficient methods for attaching non-radioactive labels to the 5' ends of synthetic oligodeoxyribonucleotides.

Authors:  S Agrawal; C Christodoulou; M J Gait
Journal:  Nucleic Acids Res       Date:  1986-08-11       Impact factor: 16.971

6.  Anticipation in myotonic dystrophy: fact or fiction?

Authors:  C J Höweler; H F Busch; J P Geraedts; M F Niermeijer; A Staal
Journal:  Brain       Date:  1989-06       Impact factor: 13.501

7.  Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member.

Authors:  J D Brook; M E McCurrach; H G Harley; A J Buckler; D Church; H Aburatani; K Hunter; V P Stanton; J P Thirion; T Hudson
Journal:  Cell       Date:  1992-02-21       Impact factor: 41.582

8.  Discrete nuclear domains of poly(A) RNA and their relationship to the functional organization of the nucleus.

Authors:  K C Carter; K L Taneja; J B Lawrence
Journal:  J Cell Biol       Date:  1991-12       Impact factor: 10.539

9.  Beta-actin mRNA localization is regulated by signal transduction mechanisms.

Authors:  V M Latham; E H Kislauskis; R H Singer; A F Ross
Journal:  J Cell Biol       Date:  1994-09       Impact factor: 10.539

10.  Sequences responsible for intracellular localization of beta-actin messenger RNA also affect cell phenotype.

Authors:  E H Kislauskis; X Zhu; R H Singer
Journal:  J Cell Biol       Date:  1994-10       Impact factor: 10.539

View more
  227 in total

Review 1.  Neurodegeneration the RNA way.

Authors:  Abigail J Renoux; Peter K Todd
Journal:  Prog Neurobiol       Date:  2011-11-03       Impact factor: 11.685

Review 2.  RNA-binding proteins in microsatellite expansion disorders: mediators of RNA toxicity.

Authors:  Gloria V Echeverria; Thomas A Cooper
Journal:  Brain Res       Date:  2012-02-22       Impact factor: 3.252

Review 3.  Structures of trinucleotide repeats in human transcripts and their functional implications.

Authors:  Anna Jasinska; Gracjan Michlewski; Mateusz de Mezer; Krzysztof Sobczak; Piotr Kozlowski; Marek Napierala; Wlodzimierz J Krzyzosiak
Journal:  Nucleic Acids Res       Date:  2003-10-01       Impact factor: 16.971

Review 4.  Imaging of single mRNAs in the cytoplasm of living cells.

Authors:  Dahlene Fusco; Edouard Bertrand; Robert H Singer
Journal:  Prog Mol Subcell Biol       Date:  2004

Review 5.  Animal models of muscular dystrophy.

Authors:  Rainer Ng; Glen B Banks; John K Hall; Lindsey A Muir; Julian N Ramos; Jacqueline Wicki; Guy L Odom; Patryk Konieczny; Jane Seto; Joel R Chamberlain; Jeffrey S Chamberlain
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

Review 6.  Epigenetics in nucleotide repeat expansion disorders.

Authors:  Fang He; Peter K Todd
Journal:  Semin Neurol       Date:  2012-01-21       Impact factor: 3.420

Review 7.  RNA-mediated neurodegeneration in repeat expansion disorders.

Authors:  Peter K Todd; Henry L Paulson
Journal:  Ann Neurol       Date:  2010-03       Impact factor: 10.422

8.  Dystrophia myotonia: why focus on foci?

Authors:  R P Junghans
Journal:  Eur J Hum Genet       Date:  2009-01-28       Impact factor: 4.246

Review 9.  Targeting RNA in mammalian systems with small molecules.

Authors:  Anita Donlic; Amanda E Hargrove
Journal:  Wiley Interdiscip Rev RNA       Date:  2018-05-03       Impact factor: 9.957

Review 10.  Myotonic dystrophy: clinical and molecular parallels between myotonic dystrophy type 1 and type 2.

Authors:  Laura P W Ranum; John W Day
Journal:  Curr Neurol Neurosci Rep       Date:  2002-09       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.